Learn more

UNIV BOSTON

Overview
  • Total Patents
    1,820
  • GoodIP Patent Rank
    3,608
  • Filing trend
    ⇧ 68.0%
About

UNIV BOSTON has a total of 1,820 patent applications. It increased the IP activity by 68.0%. Its first patent ever was published in 1972. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV YALE, UNIV UTAH RES FOUND and UNIV COLUMBIA.

Patent filings per year

Chart showing UNIV BOSTONs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cantor Charles R 113
#2 Gilchrest Barbara A 92
#3 Collins James J 67
#4 Yaar Mina 59
#5 Moustakas Theodore D 50
#6 Spira Avrum 47
#7 Eller Mark S 42
#8 Smith Cassandra L 41
#9 Ruiz-Opazo Nelson 39
#10 Grinstaff Mark W 37

Latest patents

Publication Filing date Title
US10989736B1 Cantilever-free scanning probe microscopy
WO2021081286A1 2d electrochromic metal-organic-frameworks
US2021113653A1 Cal-t constructs and uses thereof
US2021113581A1 Methods and compositions relating to lung function
US2021100475A1 Nonlinear and smart metamaterials useful to change resonance frequencies
WO2021071871A1 Electrography system employing layered electrodes for improved spatial resolution
US2020392147A1 Amidino- and amino-rocaglates as novel translation inhibitors and anticancer agents
US2020368922A1 Gripping devices and methods for making the same
WO2020232366A2 Regulated synthetic gene expression systems
WO2020256868A1 Immune system modulators for the treatment of squamous lung premalignancy
US2020355858A1 Diffractive axilenses and uses thereof
WO2020227368A1 Hsp90 inhibitors and uses thereof
US10823667B1 Engineered optical fibers and uses thereof
US2020348182A1 Systems and methods for bond-selective transient phase imaging
WO2020214650A1 Methods and compositions for modulating the immune system
WO2020214574A1 One-step flow-mediated synthesis of cannabidiol (cbd) and derivatives
US2020308234A1 Chimeric antigen receptor (car) modulation
WO2020191196A1 Systems and methods for fabricating three-dimensional conductive electrodes
US2020248274A1 Diagnostic for lung disorders using class prediction
WO2020132409A1 Stk19 inhibitors for treatment of cancer